Parallel Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1690010
SAN FRANCISCO, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$662,823
-$192,489 QoQ
Shares Held
1,063
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#738
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. REGN ranks #4 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $662,823 | 1,063 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $855,312 | 1,107 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $768,010 | 995 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $506,605 | 901 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $389,550 | 742 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $618,374 | 975 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $786,412 | 1,104 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,391,841 | 1,324 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,314,838 | 1,251 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,107,825 | 1,151 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $865,115 | 985 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,327,434 | 1,613 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $1,107,270 | 1,541 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $1,273,588 | 1,550 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $1,161,598 | 1,610 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,180,034 | 1,713 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,090,634 | 1,845 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $736,833 | 1,055 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $697,829 | 1,105 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $630,597 | 1,042 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $335,682 | 601 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $238,462 | 504 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $336,727 | 697 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $498,763 | 891 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $408,490 | 655 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $270,512 | 554 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||